CTIBIOTECH is a French biotechnology company, specialising in the development of advanced human tissue models for biomedical research and the pharmaceutical industry. Founded in 2009, the company focuses on humanised systems that provide robust alternatives to animal testing, supporting more predictive research and the development of future therapies.
Portfolio
- Human tissues for biomedical research (e.g. cancer tissues in FFPE)
- Human-derived biospecimen tools mainly from skin and blood
- CTISkin™ skin models for safety and efficacy evaluation
CTISkin™ – advanced 3D bioprinted skin models
Advanced predictive human cell bioassays for skin enable faster and more reliable preclinical testing, optimizing both time and cost efficiency.
- CTISkin™ ex vivo kits – ready-to-use human skin for bioassays
- CTISkin™ single donor kits with multiple primary cell types (keratinocytes, fibroblasts, adipocytes, sebocytes, melanocytes, blood cells)
- CTIMultiSkin – 3D bioprinted full human skin equivalents with optional added cell types (immune cells, melanocytes, endothelial cells, sebocytes)
